Mario Gennaro Mazza
Overview
Explore the profile of Mario Gennaro Mazza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1737
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mazza M, Palladini M, Villa G, De Lorenzo R, Querini P, Benedetti F
J Psychiatr Res
. 2022 Aug;
155:112-119.
PMID: 36029623
Fatigue is one of the most commonly reported symptoms in the context of the post-COVID-19 syndrome. Notably, fatigue is characterised by overlapping physical and psychopathological symptoms, and questions about its...
12.
Vai B, Mazza M, Marisa C, Beezhold J, Karkkainen H, Saunders J, et al.
Eur Psychiatry
. 2022 Aug;
65(1):e47.
PMID: 35971656
As COVID-19 becomes endemic, identifying vulnerable population groups for severe infection outcomes and defining rapid and effective preventive and therapeutic strategies remains a public health priority. We performed an umbrella...
13.
Damanti S, Cilla M, Cilona M, Fici A, Merolla A, Pacioni G, et al.
Front Med (Lausanne)
. 2022 Aug;
9:834887.
PMID: 35911387
Background: A motley postacute symptomatology may develop after COVID-19, irrespective of the acute disease severity, age, and comorbidities. Frail individuals have reduced physiological reserves and manifested a worse COVID-19 course,...
14.
Poletti S, Paolini M, Mazza M, Palladini M, Furlan R, Querini P, et al.
Eur Neuropsychopharmacol
. 2022 Jul;
61:71-77.
PMID: 35810586
SARS-CoV-2 is a novel coronavirus that mainly affects the respiratory system. However, clinical manifestations such as neurological symptoms, psychopathological outcomes and brain alterations suggest brain involvement during SARS-CoV-2 infection. Depressive...
15.
Mazza M, Palladini M, Poletti S, Benedetti F
CNS Drugs
. 2022 Jun;
36(7):681-702.
PMID: 35727534
The Coronavirus Disease 2019 (COVID-19) pandemic is still spreading worldwide over 2 years since its outbreak. The psychopathological implications in COVID-19 survivors such as depression, anxiety, and cognitive impairments are...
16.
Palladini M, Bravi B, Colombo F, Caselani E, di Pasquasio C, DOrsi G, et al.
Neuropsychol Rehabil
. 2022 May;
33(7):1207-1224.
PMID: 35583357
Cognitive impairments figure prominently in COVID-19 survivors. Cognitive remediation therapy (CRT) improves functional outcomes reducing long-term cognitive deficits in several neurological and psychiatric conditions. Our case-control study investigates the efficacy...
17.
18.
Benedetti F, Palladini M, DOrsi G, Furlan R, Ciceri F, Rovere-Querini P, et al.
J Affect Disord
. 2022 Apr;
308:554-561.
PMID: 35460737
Background: COVID-19 is associated with depressive psychopathology in survivors. Negative thinking styles are a core feature of major depression, fostering the experience of negative emotions and affects and hampering recovery....
19.
Benedetti F, Zanardi R, Mazza M
Int Clin Psychopharmacol
. 2022 Mar;
37(3):79-81.
PMID: 35357329
Raised inflammatory setpoints have been associated with major depression and its detrimental consequences on brain function, as they lead to increased production of cytokines, changes in gene expression and activated...
20.
Mazza M, Vai B, De Picker L, Benedetti F, Zanardi R
Drugs
. 2022 Feb;
82(3):349-351.
PMID: 35150437
No abstract available.